Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Epilepsy Research|July 3, 2025
Theta functional connectivity alterations related to executive control in refractory temporal lobe epilepsyChangqing Zhan, Qiao Wang, Wenyu Wang, et al.
Frontiers in Medicine|March 25, 2026
Cognitive function in normotensive elderly adults: a population-based cross-sectional study in rural ChinaChangqing Zhan, Qiao Wang, Yingnian Chen, et al.
CNS Neuroscience & Therapeutics|June 12, 2025
Task-Evoked Theta Oscillation Dysregulation Underlies Attention Network Deficits in Left Temporal Lobe Drug-Resistant EpilepsyChangqing Zhan, Qiao Wang, Wenyu Wang, et al.
Cell Transplantation|January 28, 2025
The Combination of Intravenous Immunoglobulin, Dexamethasone, and a High Dose of Mononuclear Cells Transfusion: An Effective Strategy for Decreasing Donor-Specific Antibodies During Haploidentical Hematopoietic Stem Cell TransplantationXiaoping Li, Yu Li, Dingsong Zhang, et al.
Ejhaem|June 19, 2024
Stable engraftment, as well as graft versus host disease-free and relapse-free survival brought by the combination of CD7 targeted universal chimeric antigen receptor-T, and donor hemopoietic stem cells: Indication of a case reportShiqi Li, Zhongtao Yuan, Lin Liu, et al.
Cell Stem Cell|May 17, 2024
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trialShiqi Li, Sikai Ling, Dawei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2020
Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS ManagementShiqi Li, Xinxin Wang, Zhongtao Yuan, et al.
Ejhaem|August 19, 2024
Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective studyJieling Jiang, Xiaofan Li, Dong Wu, et al.
Leukemia|September 12, 2023
CD7 targeted "off-the-shelf" CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignanciesShiqi Li, Xinxin Wang, Lin Liu, et al.
Pageof 1